ArticleBMC infectious diseases2025
Prevalence of human papillomavirus infection and its associations with metabolic risk factors in China: a nationwide population-based study.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundThe association between metabolic risk factors and human papillomavirus (HPV) infection is under debate. This study aimed to investigate the associations between metabolic risk factors and HPV infection, while also providing updated data on the prevalence of HPV infection in the post-vaccine era in China.
methodsThis cross-sectional study involved 684,632 adult women who had undergone a standard health screening in 2019. HPV infection prevalence was estimated. Linear and nonlinear associations between HPV infection and metabolic risk factors were assessed, such as body mass index (BMI), systolic blood pressure (SBP), fasting plasma glucose (FPG), and low-density lipoprotein (LDL).
resultsThe standardized prevalence of overall and high-risk HPV infection was 16.2% (95% confidence interval [95%CI]: 15.1-17.3) and 12.8% (95%CI: 11.8-13.7), respectively. HPV infection was negatively associated with BMI, with women in the highest quartile having the lowest odds of infection compared to those in the lowest quartile (odds ratio [OR] = 0.84, 95%CI: 0.78-0.91, P < 0.0001), indicating a significant linear trend (P
conclusionsThe prevalence of HPV infection in China remains high, and metabolic risk factors might be associated with an increased susceptibility to HPV. Longitudinal studies are needed to validate the association between metabolic risk factors and HPV infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.